• Kestra Medical Technologies President and Chief Executive Officer Brian Daniel Webster sold 15,000 common shares on October 20, 2026.
• Sales comprised 13,316 shares at $29.5172 each and 1,684 shares at $29.892 each.
• Webster directly owned 445,215 common shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kestra Medical Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-428976), on October 22, 2026, and is solely responsible for the information contained therein.